The Dougherty lab published a paper recently in eNeuro. The paper, “Examining the Reversibility of Long-Term Behavioral Disruptions in Progeny of Maternal SSRI Exposure,” looks at how maternal fluoxetine treatment can induce behavioral disruptions in mammalian offspring, contributing to our understanding of the developmental role of the serotonin system and the possible risks to offspring of SSRI treatment during pregnancy. Susan E. Maloney, Ph.D., Instructor in Psychiatry at Washington University School of Medicine and a member of Dr. Joe Dougherty’s lab, is first author on the paper. Read the study abstract here.
